Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation.
about
Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD.Recent advances in pre-clinical mouse models of COPD.The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models.Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.Cigarette smoke exposure as a model of inflammation associated with COPD.Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease.Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro.Toxicological evaluation of aerosols of a tobacco extract formulation and nicotine formulation in acute and short-term inhalation studies.Short-term exposure of mice to cigarette smoke and/or residual oil fly ash produces proximal airspace enlargements and airway epithelium remodeling.Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD.Atorvastatin and Simvastatin Promoted Mouse Lung Repair After Cigarette Smoke-Induced Emphysema.
P2860
Q36775140-ADAFDB4D-96A8-46E3-B8FC-55B4E8D98676Q37426720-D9B33555-EAB0-42D0-95B2-3A78DAEC039DQ37532493-9C53B2CA-2883-4106-8B7F-4A5034EE5E21Q37891587-84482821-1A52-40EF-9B39-88A1E7148A7AQ38781034-BFB2006C-31DB-4668-9902-075435D1D3B1Q40796195-0822EC2C-7360-4692-B2CB-F98E14306E90Q46328869-6D7B8D0F-A830-4BD6-8EE5-112E9768CA66Q46812072-1E93A959-C417-4722-B071-A76BB6869D39Q46840799-E564965A-25B0-4323-9B23-EA41DFF66619Q51158282-03C640AC-9D73-46C6-A56E-1DC4FC5F46FBQ51485466-FF5C6712-E1B9-47ED-A3BA-00601324B02AQ51703615-52014E02-CCBF-4DCE-ABAA-F6169F22996EQ53519181-159D1C75-B1A2-429B-AD2E-18962585237D
P2860
Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacological characterisati ...... te smoke-induced inflammation.
@ast
Pharmacological characterisati ...... te smoke-induced inflammation.
@en
Pharmacological characterisati ...... te smoke-induced inflammation.
@nl
type
label
Pharmacological characterisati ...... te smoke-induced inflammation.
@ast
Pharmacological characterisati ...... te smoke-induced inflammation.
@en
Pharmacological characterisati ...... te smoke-induced inflammation.
@nl
prefLabel
Pharmacological characterisati ...... te smoke-induced inflammation.
@ast
Pharmacological characterisati ...... te smoke-induced inflammation.
@en
Pharmacological characterisati ...... te smoke-induced inflammation.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacological characterisati ...... te smoke-induced inflammation.
@en
P2093
Abigail Morris
Christopher S Stevenson
Daniel Wyss
Gillian Kinnear
Joanie Mok
William Pearce
Wing-Yan Heidi Wan
P2860
P2888
P356
10.1186/1465-9921-11-126
P577
2010-09-18T00:00:00Z
P5875
P6179
1012293390